AnnJi Pharmaceutical Co., Ltd. (TPEX:7754)
Taiwan
· Delayed Price · Currency is TWD 45.85
-0.45 (-0.97%)
At close: Dec 5, 2025
AnnJi Pharmaceutical Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -317.13 | -353.99 | -329.22 | -236.65 | -198.63 |
| Depreciation & Amortization | 44.42 | 44.3 | 37.74 | 40.05 | 41.51 |
| Other Amortization | 0.76 | 0.65 | 0.55 | 0.38 | 0.12 |
| Loss (Gain) From Sale of Assets | -0.09 | -0.09 | -0.2 | -0.34 | - |
| Loss (Gain) From Sale of Investments | 1.68 | 4.54 | 29.42 | - | - |
| Stock-Based Compensation | 7.19 | 46.78 | 48.2 | 6.66 | 3.02 |
| Other Operating Activities | -14.96 | -0.47 | 38.92 | - | -0.01 |
| Change in Accounts Receivable | -0.07 | -0.15 | 0.09 | -0.09 | - |
| Change in Inventory | 3.88 | -27.42 | - | - | - |
| Change in Accounts Payable | -2.13 | 0.12 | - | 15.66 | 4.39 |
| Change in Unearned Revenue | 43.78 | 66.65 | 89.56 | 1.6 | - |
| Change in Other Net Operating Assets | -59.22 | 33.06 | 17.73 | -16.75 | 9.21 |
| Operating Cash Flow | -291.89 | -186.01 | -67.2 | -189.49 | -140.39 |
| Capital Expenditures | -2.23 | -9.95 | -12.04 | -1.58 | -3.23 |
| Sale of Property, Plant & Equipment | 0.09 | 0.09 | 0.26 | 0.36 | - |
| Sale (Purchase) of Intangibles | -1.04 | -0.56 | -0.35 | -0.42 | -0.52 |
| Investment in Securities | 96 | 198 | -274 | - | 100 |
| Other Investing Activities | -0.01 | 0.74 | -1.9 | - | 0.39 |
| Investing Cash Flow | 92.81 | 188.31 | -288.02 | -1.65 | 96.65 |
| Short-Term Debt Repaid | - | - | - | - | -17.08 |
| Long-Term Debt Repaid | - | -5.95 | - | -2.79 | -3.25 |
| Total Debt Repaid | -6.05 | -5.95 | - | -2.79 | -20.33 |
| Net Debt Issued (Repaid) | -6.05 | -5.95 | - | -2.79 | -20.33 |
| Issuance of Common Stock | 4.9 | 33.02 | 685.18 | 70 | 364.5 |
| Other Financing Activities | 1.82 | 1.82 | - | -0.16 | - |
| Financing Cash Flow | 0.67 | 28.89 | 685.18 | 67.05 | 344.17 |
| Foreign Exchange Rate Adjustments | - | - | - | 0.57 | -0.57 |
| Net Cash Flow | -198.4 | 31.19 | 329.96 | -123.51 | 299.85 |
| Free Cash Flow | -294.12 | -195.97 | -79.23 | -191.07 | -143.62 |
| Free Cash Flow Margin | -1233.09% | -203.18% | -55.20% | -11750.92% | -10008.22% |
| Free Cash Flow Per Share | -3.14 | -2.11 | -1.02 | -2.91 | -3.18 |
| Cash Interest Paid | 2.16 | 2.25 | - | 0.03 | 0.15 |
| Cash Income Tax Paid | - | - | -0.01 | 1.59 | -0.01 |
| Levered Free Cash Flow | -312.78 | -78.57 | 93.18 | -104.84 | - |
| Unlevered Free Cash Flow | -311.72 | -77.46 | 93.47 | -104.82 | - |
| Change in Working Capital | -13.75 | 72.26 | 107.38 | 0.42 | 13.6 |
Source: S&P Capital IQ. Standard template. Financial Sources.